GlassScriptPhysician profile
Jagadeesh C Reddy
NPI 1083610703
$84,648.04
in general payments reported to CMS, 2019-2025
9 companies · $11K in 2025
The $11K reported for 2025 was more than what 93% of Infectious Disease providers received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $7,095 · 2021: $8,005 · 2022: $16K · 2023: $14K · 2024: $13K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $15K · Food and Beverage: $1,982 · Travel and Lodging: $1,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20,385.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $14,745.00 |
| Food and Beverage | $1,981.92 |
| Travel and Lodging | $1,134.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $29,342.08 | 2021-2025 | |
| Shionogi INC | $27,641.11 | 2022-2025 | Fetroja |
| Merck Sharp & Dohme LLC | $16,776.42 | 2019-2025 | Zerbaxa |
| Allergan, INC. | $10,411.36 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $154.29 | 2025 | Lifevest |
| Gilead Sciences, INC. | $117.85 | 2025 | Yeztugo |
| Glaxosmithkline, LLC. | $90.91 | 2021 | |
| Pfizer INC. | $76.13 | 2025 | |
| Janssen Pharmaceuticals, INC | $37.89 | 2024 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jagadeesh Reddy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.